Related Experiment Videos
Angiogenesis and angiogenesis inhibitors in paediatric diseases
1Children's Hospital, Ruprecht-Karls-University, Heidelberg, Federal Republic of Germany.
Insights
New blood vessel formation, known as angiogenesis, is uncommon in healthy individuals but occurs in childhood diseases. This review covers advances in understanding pathological angiogenesis and new therapies for angiogenic pediatric conditions.
Area of Science:
- Vascular Biology
- Pediatric Pathology
- Medical Research
Background:
- Angiogenesis, the formation of new blood vessels, is typically limited in healthy organisms.
- However, it is a significant factor in various pediatric diseases.
- Understanding the mechanisms of pathological angiogenesis is crucial for developing effective treatments.
Purpose of the Study:
- To review recent advancements in understanding pathological angiogenesis.
- To explore novel therapeutic strategies for angiogenic childhood diseases.
- To provide an updated perspective on the field for researchers and clinicians.
Main Methods:
- Literature review of recent scientific publications.
- Analysis of studies focusing on molecular mechanisms of angiogenesis.
- Examination of clinical trials and therapeutic approaches for pediatric angiogenic disorders.
Main Results:
- Recent research has elucidated key pathways driving pathological angiogenesis in children.
- Several promising therapeutic targets and drug candidates are emerging.
- Progress has been made in understanding the specific roles of angiogenesis in different pediatric conditions.
Conclusions:
- Pathological angiogenesis is a critical hallmark of several pediatric diseases.
- Targeting angiogenic pathways offers a promising avenue for novel pediatric therapies.
- Continued research is essential to translate these findings into effective clinical treatments for children.
Abstract:
Angiogenesis, the generation of new capillaries from existing blood vessels, is rarely observed in the healthy organism, but can present during various paediatric diseases. In this review, we describe recent progress in the understanding of pathological angiogenesis and approaches for an improved therapy of angiogenic childhood diseases.